Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -47,867 | -53,260 | -23,873 | -6,832 |
| Depreciation Amortization | 197 | 111 | 12 | 1 |
| Accounts payable and accrued liabilities | 2,246 | 6 | 186 | -89 |
| Other Working Capital | 171 | 4,221 | 395 | 218 |
| Other Operating Activity | 4,090 | 20,657 | 1,494 | 3,130 |
| Operating Cash Flow | $-41,163 | $-28,265 | $-21,786 | $-3,572 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | N/A | 10,010 | -10,020 | N/A |
| PPE Investments | -171 | -414 | -187 | -2 |
| Other Investing Activity | 25 | -150 | -75 | 0 |
| Investing Cash Flow | $-146 | $9,446 | $-10,282 | $-2 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 211 | 147,301 | 405 | 25 |
| Other Financing Activity | -15 | -7,425 | 58,388 | 4,664 |
| Financing Cash Flow | $196 | $139,876 | $58,793 | $4,689 |
| Exchange Rate Effect | -60 | -31 | N/A | N/A |
| Beginning Cash Position | 150,180 | 29,154 | 2,429 | 1,314 |
| End Cash Position | 109,007 | 150,180 | 29,154 | 2,429 |
| Net Cash Flow | $-41,173 | $121,026 | $26,725 | $1,115 |
| Free Cash Flow | ||||
| Operating Cash Flow | -41,163 | -28,265 | -21,786 | -3,572 |
| Capital Expenditure | -214 | -414 | -187 | -2 |
| Free Cash Flow | -41,377 | -28,679 | -21,973 | -3,574 |